These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31660082)

  • 1. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles.
    Deng G; Ma C; Zhao H; Zhang S; Liu J; Liu F; Chen Z; Chen AT; Yang X; Avery J; Zou P; Du F; Lim KP; Holden D; Li S; Carson RE; Huang Y; Chen Q; Kimberly WT; Simard JM; Sheth KN; Zhou J
    Theranostics; 2019; 9(23):6991-7002. PubMed ID: 31660082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy.
    Wu H; Peng B; Mohammed FS; Gao X; Qin Z; Sheth KN; Zhou J; Jiang Z
    Small; 2022 Jun; 18(22):e2107126. PubMed ID: 35306743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.
    Ma J; Zhang S; Liu J; Liu F; Du F; Li M; Chen AT; Bao Y; Suh HW; Avery J; Deng G; Zhou Y; Wu P; Sheth K; Wang H; Zhou J
    Small; 2019 Aug; 15(35):e1902011. PubMed ID: 31290245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery.
    Zhang S; Peng B; Chen Z; Yu J; Deng G; Bao Y; Ma C; Du F; Sheu WC; Kimberly WT; Simard JM; Coman D; Chen Q; Hyder F; Zhou J; Sheth KN
    Bioact Mater; 2022 Oct; 16():57-65. PubMed ID: 35386312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy.
    Guo X; Deng G; Liu J; Zou P; Du F; Liu F; Chen AT; Hu R; Li M; Zhang S; Tang Z; Han L; Liu J; Sheth KN; Chen Q; Gou X; Zhou J
    ACS Nano; 2018 Aug; 12(8):8723-8732. PubMed ID: 30107729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
    Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q
    J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
    Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
    Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
    Zadeh Mehrizi T; Khamesipour A; Shafiee Ardestani M; Ebrahimi Shahmabadi H; Haji Molla Hoseini M; Mosaffa N; Ramezani A
    Int J Nanomedicine; 2019; 14():7593-7607. PubMed ID: 31802863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease.
    Chen T; Liu W; Xiong S; Li D; Fang S; Wu Z; Wang Q; Chen X
    ACS Appl Mater Interfaces; 2019 Dec; 11(48):45276-45289. PubMed ID: 31638771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of betulinic acid nanoformulations.
    Saneja A; Arora D; Kumar R; Dubey RD; Panda AK; Gupta PN
    Ann N Y Acad Sci; 2018 Jun; 1421(1):5-18. PubMed ID: 29377164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of NOX4 by betulinic acid protects against cerebral ischemia-reperfusion in mice.
    Lu P; Zhang CC; Zhang XM; Li HG; Luo AL; Tian YK; Xu H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):744-749. PubMed ID: 29058289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment.
    Dutta D; Al Hoque A; Paul B; Park JH; Chowdhury C; Quadir M; Banerjee S; Choudhury A; Laha S; Sepay N; Boro P; Kaipparettu BA; Mukherjee B
    J Biomed Sci; 2024 Aug; 31(1):81. PubMed ID: 39164686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): part I. Albumin-bound betulinic acid nanoparticles (ABBns).
    Srivari Y; Chatterjee P
    J Microencapsul; 2016 Dec; 33(8):689-701. PubMed ID: 27707051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
    Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
    Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment of betulinic acid, a PTP1B inhibitor, with Orthosiphon stamineus extract decreases body weight in high-fat-fed mice.
    Choi YJ; Park SY; Kim JY; Won KC; Kim BR; Son JK; Lee SH; Kim YW
    J Med Food; 2013 Jan; 16(1):2-8. PubMed ID: 23256448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid, isolated from the leaves of Syzygium cumini (L.) Skeels, ameliorates the proteinuria in experimental membranous nephropathy through regulating Nrf2/NF-κB pathways.
    Sutariya B; Taneja N; Saraf M
    Chem Biol Interact; 2017 Aug; 274():124-137. PubMed ID: 28711658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of intravenous glyburide in patients with a large ischemic stroke.
    Sheth KN; Kimberly WT; Elm JJ; Kent TA; Mandava P; Yoo AJ; Thomalla G; Campbell B; Donnan GA; Davis SM; Albers GW; Jacobson S; Simard JM; Stern BJ
    Stroke; 2014 Jan; 45(1):281-3. PubMed ID: 24193798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.
    Sheth KN; Elm JJ; Molyneaux BJ; Hinson H; Beslow LA; Sze GK; Ostwaldt AC; Del Zoppo GJ; Simard JM; Jacobson S; Kimberly WT
    Lancet Neurol; 2016 Oct; 15(11):1160-9. PubMed ID: 27567243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.